About Blueprint Genetics
Blueprint Genetics a Stanford University spin-off focused on the development of state-of-the-art genetic diagnostics for hereditary diseases. The company was founded around a proprietary sequencing technology, OS-Seq, which enables very high quality sequencing with faster turn-around-time and lower costs. In the last two years, Blueprint Genetics has been expanding in the global genetic diagnostics market. As a proof of concept for the company and its technological innovations, our main focus has been hereditary cardiovascular diseases. In 2016, Blueprint is extending its offering to all human hereditary diseases and continues expanding its operations globally. Blueprint Genetics offers an exciting opportunity to work in a start-up environment in one of the most exciting fields of medicine.